Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESOC 2022 | Targeting blood pressure to reduce hemorrhagic risk after endovascular therapy

Mikael Mazighi, MD, Université de Paris, Paris, France, shares his thoughts on the importance of blood pressure control after endovascular therapy (EVT). Several recent studies have demonstrated a link between blood pressure management after EVT and intracranial hemorrhage (ICH) risk. The recent Blood Pressure Target in Acute Ischemic Stroke to Reduce Hemorrhage After Endovascular Therapy (BP TARGET) trial (NCT03160677), evaluating whether an intensive systolic blood pressure target of below 130mmHg resulted in reduced rates of ICH, had a neutral outcome. Investigators are now seeing if other reduction strategies or individually tailored approaches can reduce hemorrhagic risk in this population. This interview took place at European Stroke Organisation Conference 2022 in Lyon, France.


Prof. Mazighi reports the following disclosures:
Consulting activities for: Acticor Biotech, Air liquid, Boerhinger Ingelheim, & Novonordisk.